Biogen (BIIB) PT Raised to $241 at Mizuho

August 4, 2026 6:39 AM

Mizuho analyst Salim Syed raised the price target on Biogen (NASDAQ: BIIB) to $241.00 (from $221.00) while maintaining a Outperform rating.

No results found